Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 23/07/24 → 23/07/26 |
Keywords
- clinical trial
- vitiligo
- Ritlecitinib
Clinical Trial Phase
- Phase III (a & b)
A Phase 3 Randomized Withdrawal And Dose-Up Titration, Multi- Center Extension Study Investigating The Safety, Efficacy, And Tolerability Of Ritlecitinib In Adult And Adolescent Participants With Nonsegmental Vitiligo
- Kern, Johannes (Primary Chief Investigator (PCI))
Project: Research